BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Eren F, Ozdogan O, Celikel CA, Imeryuz N, Kalayci C, Avsar E. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol. 2011;46:91-97. [PMID: 20809771 DOI: 10.3109/00365521.2010.516452] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Hatziagelaki E, Herder C, Tsiavou A, Teichert T, Chounta A, Nowotny P, Pacini G, Dimitriadis G, Roden M. Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD). PLoS One. 2015;10:e0124935. [PMID: 25933030 DOI: 10.1371/journal.pone.0124935] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
2 Ahn KY, Lee MK, Kim DI, Park J, Min J, Yang H, Lee J, Oh M, An J, Lee JW, Chu SH, Meyerhardt JA, Kim NK, Jeon JY. Cardiopulmonary fitness, adiponectin, chemerin associated fasting insulin level in colorectal cancer patients. Support Care Cancer 2016;24:2927-35. [PMID: 26847448 DOI: 10.1007/s00520-016-3095-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Derosa G, Cicero AF, Franzetti IG, Querci F, Carbone A, Ciccarelli L, D’angelo A, Fogari E, Maffioli P. Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapy. Can J Physiol Pharmacol 2013;91:724-32. [DOI: 10.1139/cjpp-2012-0300] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zhou Y, Zhang B, Hao C, Huang X, Li X, Huang Y, Luo Z. Omentin-A Novel Adipokine in Respiratory Diseases. Int J Mol Sci 2017;19:E73. [PMID: 29283409 DOI: 10.3390/ijms19010073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
5 Li Z, Liu B, Zhao D, Wang B, Liu Y, Zhang Y, Li B, Tian F. Omentin-1 prevents cartilage matrix destruction by regulating matrix metalloproteinases. Biomedicine & Pharmacotherapy 2017;92:265-9. [DOI: 10.1016/j.biopha.2017.05.059] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
6 Zhang J, Li K, Pan L, Teng F, Zhang P, Lin B, Yuan Y, Wei X, Li W, Zhang H. Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study. BMC Gastroenterol 2021;21:131. [PMID: 33743586 DOI: 10.1186/s12876-021-01721-9] [Reference Citation Analysis]
7 Imai K, Takai K, Hanai T, Shiraki M, Suzuki Y, Hayashi H, Naiki T, Nishigaki Y, Tomita E, Shimizu M, Moriwaki H. Impact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma. Int J Mol Sci 2014;15:11294-306. [PMID: 24968270 DOI: 10.3390/ijms150711294] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
8 Ye Z, Wang S, Yang Z, He M, Zhang S, Zhang W, Wen J, Li Q, Huang Y, Wang X, Lu B, Zhang Z, Su Q, Hu R. Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease. Mol Biol Rep 2014;41:1317-23. [PMID: 24390241 DOI: 10.1007/s11033-013-2977-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
9 Sengul E, Duygulu G, Dindar S, Bunul F. Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease. Renal Failure 2013;35:1089-93. [DOI: 10.3109/0886022x.2013.817256] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Aliasghari F, Izadi A, Jabbari M, Imani B, Gargari BP, Asjodi F, Ebrahimi S. Are Vaspin and Omentin-1 Related to Insulin Resistance, Blood Pressure and Inflammation in NAFLD Patients? J Med Biochem 2018;37:470-5. [PMID: 30584407 DOI: 10.2478/jomb-2018-0006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
11 Eisinger K, Krautbauer S, Wiest R, Weiss TS, Buechler C. Reduced serum chemerin in patients with more severe liver cirrhosis. Exp Mol Pathol 2015;98:208-13. [PMID: 25595667 DOI: 10.1016/j.yexmp.2015.01.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
12 Kim JA, Choi KM. Newly Discovered Adipokines: Pathophysiological Link Between Obesity and Cardiometabolic Disorders. Front Physiol 2020;11:568800. [PMID: 32982804 DOI: 10.3389/fphys.2020.568800] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
13 Moodi M, Tavakoli T, Tahergorabi Z. Crossroad between Obesity and Gastrointestinal Cancers: A Review of Molecular Mechanisms and Interventions. Int J Prev Med 2021;12:18. [PMID: 34084315 DOI: 10.4103/ijpvm.IJPVM_266_20] [Reference Citation Analysis]
14 Levin LM, Völzke H, Lerch MM, Kühn JP, Nauck M, Friedrich N, Zylla S. Associations of circulating chemerin and adiponectin concentrations with hepatic steatosis. Endocr Connect 2019;8:1097-107. [PMID: 31265993 DOI: 10.1530/EC-19-0300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Adolph TE, Grander C, Grabherr F, Tilg H. Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. Int J Mol Sci 2017;18:E1649. [PMID: 28758929 DOI: 10.3390/ijms18081649] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 17.8] [Reference Citation Analysis]
16 Bekaert M, Ouwens DM, Hörbelt T, Van de Velde F, Fahlbusch P, Herzfeld de Wiza D, Van Nieuwenhove Y, Calders P, Praet M, Hoorens A, Geerts A, Verhelst X, Kaufman J, Lapauw B. Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity: Chemerin Expression in Patients with NAFLD. Obesity 2016;24:2544-52. [DOI: 10.1002/oby.21674] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
17 Niklowitz P, Rothermel J, Lass N, Barth A, Reinehr T. Link between chemerin, central obesity, and parameters of the Metabolic Syndrome: findings from a longitudinal study in obese children participating in a lifestyle intervention. Int J Obes 2018;42:1743-52. [DOI: 10.1038/s41366-018-0157-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 9.3] [Reference Citation Analysis]
18 Chu SH, Lee MK, Ahn KY, Im JA, Park MS, Lee DC, Jeon JY, Lee JW. Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS One. 2012;7:e34710. [PMID: 22509348 DOI: 10.1371/journal.pone.0034710] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 6.6] [Reference Citation Analysis]
19 Ansari MHK, Gholamnejad M, Meghrazi K, Khalkhali HR. Association of circulating omentin-1 level with lung cancer in smokers. Med J Islam Repub Iran 2018;32:133. [PMID: 30815428 DOI: 10.14196/mjiri.32.133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
20 Polyzos SA, Kountouras J, Mantzoros CS. Adipokines in nonalcoholic fatty liver disease. Metabolism 2016;65:1062-79. [DOI: 10.1016/j.metabol.2015.11.006] [Cited by in Crossref: 147] [Cited by in F6Publishing: 131] [Article Influence: 29.4] [Reference Citation Analysis]
21 Jacenik D, Fichna J. Chemerin in immune response and gastrointestinal pathophysiology. Clin Chim Acta 2020;504:146-53. [PMID: 32070869 DOI: 10.1016/j.cca.2020.02.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Kukla M, Adamek B, Waluga M, Zalewska-Ziob M, Kasperczyk J, Gabriel A, Mazur W, Sobala-Szczygieł B, Bułdak RJ, Zajęcki W, Kępa L, Ziora K, Żwirska-Korczala K, Wiczkowski A, Hartleb M. Hepatic chemerin and chemokine-like receptor 1 expression in patients with chronic hepatitis C. Biomed Res Int 2014;2014:517820. [PMID: 25121101 DOI: 10.1155/2014/517820] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
23 Bekaert M, Verhelst X, Geerts A, Lapauw B, Calders P. Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review. Obes Rev. 2016;17:68-80. [PMID: 26597657 DOI: 10.1111/obr.12333] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
24 Patnaik K, Pradeep AR, Nagpal K, Karvekar S, Singh P, Raju A. Human chemerin correlation in gingival crevicular fluid and tear fluid as markers of inflammation in chronic periodontitis and type-2 diabetes mellitus. J Investig Clin Dent 2017;8. [PMID: 26224661 DOI: 10.1111/jicd.12181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
25 Lesná J, Tichá A, Hyšpler R, Musil F, Bláha V, Sobotka L, Zadák Z, Šmahelová A. Omentin-1 plasma levels and cholesterol metabolism in obese patients with diabetes mellitus type 1: impact of weight reduction. Nutr Diabetes 2015;5:e183. [PMID: 26524638 DOI: 10.1038/nutd.2015.33] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
26 Katsi V, Vamvakou G, Lekakis J, Tousoulis D, Stefanadis C, Makris T, Kallikazaros I. Omentin, Fat and Heart: Classical Music with New Instruments. Heart, Lung and Circulation 2014;23:802-6. [DOI: 10.1016/j.hlc.2014.03.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
27 Zhou Z, Chen H, Ju H, Sun M. Circulating chemerin levels and gestational diabetes mellitus: a systematic review and meta-analysis. Lipids Health Dis 2018;17:169. [PMID: 30041634 DOI: 10.1186/s12944-018-0826-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
28 Zehsaz F, Farhangi N, Ghahramani M. The response of circulating omentin-1 concentration to 16-week exercise training in male children with obesity. The Physician and Sportsmedicine 2016;44:355-61. [DOI: 10.1080/00913847.2016.1248223] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
29 Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol 2014;20:9330-7. [PMID: 25071327 DOI: 10.3748/wjg.v20.i28.9330] [Cited by in F6Publishing: 105] [Reference Citation Analysis]
30 Rourke JL, Dranse HJ, Sinal CJ. Towards an integrative approach to understanding the role of chemerin in human health and disease. Obes Rev. 2013;14:245-262. [PMID: 23216632 DOI: 10.1111/obr.12009] [Cited by in Crossref: 111] [Cited by in F6Publishing: 104] [Article Influence: 12.3] [Reference Citation Analysis]
31 Gu P, Cheng M, Hui X, Lu B, Jiang W, Shi Z. Elevating circulation chemerin level is associated with endothelial dysfunction and early atherosclerotic changes in essential hypertensive patients. Journal of Hypertension 2015;33:1624-32. [DOI: 10.1097/hjh.0000000000000588] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
32 Catalina MO, Redondo PC, Granados MP, Cantonero C, Sanchez-Collado J, Albarran L, Lopez JJ. New Insights into Adipokines as Potential Biomarkers for Type-2 Diabetes Mellitus. Curr Med Chem 2019;26:4119-44. [PMID: 29210636 DOI: 10.2174/0929867325666171205162248] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
33 Zhou Q, Ge Q, Ding Y, Qu H, Wei H, Wu R, Yao L, Wei Q, Feng Z, Long J, Deng H. Relationship between serum adipsin and the first phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance. J Diabetes Investig 2018;9:1128-34. [PMID: 29432659 DOI: 10.1111/jdi.12819] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
34 Elpek GÖ. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol 2014;20:7260-76. [PMID: 24966597 DOI: 10.3748/wjg.v20.i23.7260] [Cited by in CrossRef: 161] [Cited by in F6Publishing: 140] [Article Influence: 26.8] [Reference Citation Analysis]
35 Prats-Puig A, Bassols J, Bargalló E, Mas-Parareda M, Ribot R, Soriano-Rodríguez P, Berengüí A, Díaz M, de Zegher F, Ibánez L. Toward an early marker of metabolic dysfunction: omentin-1 in prepubertal children. Obesity (Silver Spring). 2011;19:1905-1907. [PMID: 21720428 DOI: 10.1038/oby.2011.198] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
36 Krautbauer S, Wanninger J, Eisinger K, Hader Y, Beck M, Kopp A, Schmid A, Weiss TS, Dorn C, Buechler C. Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Experimental and Molecular Pathology 2013;95:199-205. [DOI: 10.1016/j.yexmp.2013.07.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
37 Izadi A, Aliasghari F, Gargari BP, Ebrahimi S. Strong association between serum Vitamin D and Vaspin Levels, AIP, VAI and liver enzymes in NAFLD patients. Int J Vitam Nutr Res 2020;90:59-66. [PMID: 30932788 DOI: 10.1024/0300-9831/a000443] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 İnci S, Aksan G, Doğan P. Chemerin as an independent predictor of cardiovascular event risk. Ther Adv Endocrinol Metab 2016;7:57-68. [PMID: 27092231 DOI: 10.1177/2042018816629894] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
39 González-López MA, Ocejo-Viñals JG, Mata C, Díaz D, Guiral S, Portilla V, Corrales A, González-Vela MC, González-Gay MA, Blanco R, Hernández JL. Evaluation of serum omentin-1 and apelin concentrations in patients with hidradenitis suppurativa. Postepy Dermatol Alergol 2021;38:450-4. [PMID: 34377127 DOI: 10.5114/ada.2021.107932] [Reference Citation Analysis]
40 Eisinger K, Krautbauer S, Wiest R, Karrasch T, Hader Y, Scherer MN, Farkas S, Aslanidis C, Buechler C. Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension. Eur J Clin Invest. 2013;43:926-932. [PMID: 23855493 DOI: 10.1111/eci.12122] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
41 Buechler C, Wanninger J, Neumeier M. Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol 2011;17:2801-11. [PMID: 21734787 DOI: 10.3748/wjg.v17.i23.2801] [Cited by in F6Publishing: 86] [Reference Citation Analysis]
42 Diot M, Reverchon M, Rame C, Froment P, Brillard JP, Brière S, Levêque G, Guillaume D, Dupont J. Expression of adiponectin, chemerin and visfatin in plasma and different tissues during a laying season in turkeys. Reprod Biol Endocrinol 2015;13:81. [PMID: 26228641 DOI: 10.1186/s12958-015-0081-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
43 Yilmaz Y, Kurt R, Gurdal A, Alahdab YO, Yonal O, Senates E, Polat N, Eren F, Imeryuz N, Oflaz H. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis. 2011;217:125-129. [PMID: 21513939 DOI: 10.1016/j.atherosclerosis.2011.03.026] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
44 He J, Li JC, Xie H, Xu ZH, Sun YW, Shan Q. Serum Chemerin Levels in relation to Osteoporosis and Bone Mineral Density: A Case-Control Study. Dis Markers 2015;2015:786708. [PMID: 26170530 DOI: 10.1155/2015/786708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
45 Sledzińska M, Szlagatys-Sidorkiewicz A, Brzezinski M, Kaźmierska K, Sledziński T, Kamińska B. Serum chemerin in children with excess body weight may be associated with ongoing metabolic complications - A pilot study. Adv Med Sci 2017;62:383-6. [PMID: 28551507 DOI: 10.1016/j.advms.2017.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
46 Kukla M, Waluga M, Żorniak M, Berdowska A, Wosiewicz P, Sawczyn T, Bułdak RJ, Ochman M, Ziora K, Krzemiński T, Hartleb M. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis. World J Gastroenterol 2017;23:2613-24. [PMID: 28465646 DOI: 10.3748/wjg.v23.i14.2613] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
47 Esteghamati A, Noshad S, Rabizadeh S, Ghavami M, Zandieh A, Nakhjavani M. Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial. Regul Pept 2013;182:1-6. [PMID: 23328000 DOI: 10.1016/j.regpep.2012.12.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
48 Kucukoglu O, Sowa JP, Mazzolini GD, Syn WK, Canbay A. Hepatokines and adipokines in NASH-related hepatocellular carcinoma. J Hepatol. 2021;74:442-457. [PMID: 33161047 DOI: 10.1016/j.jhep.2020.10.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
49 Kyohara M, Shirakawa J, Okuyama T, Togashi Y, Inoue R, Li J, Miyashita D, Terauchi Y. Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects. Diabetol Metab Syndr 2020;12:83. [PMID: 33005239 DOI: 10.1186/s13098-020-00591-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Tan YL, Zheng XL, Tang CK. The protective functions of omentin in cardiovascular diseases. Clin Chim Acta 2015;448:98-106. [PMID: 26079253 DOI: 10.1016/j.cca.2015.05.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
51 Yilmaz Y, Eren F. Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. Clin Chim Acta 2012;414:154-7. [PMID: 22985537 DOI: 10.1016/j.cca.2012.08.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
52 Pohl R, Haberl EM, Rein-Fischboeck L, Zimny S, Neumann M, Aslanidis C, Schacherer D, Krautbauer S, Eisinger K, Weiss TS, Buechler C. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis. Eur J Clin Invest 2017;47:7-18. [PMID: 27797398 DOI: 10.1111/eci.12695] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
53 Jung CH, Jung SH, Kim BY, Kim CH, Kang SK, Mok JO. Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study. Cardiovasc Diabetol 2015;14:140. [PMID: 26466574 DOI: 10.1186/s12933-015-0303-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
54 Bondue B, Wittamer V, Parmentier M. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine & Growth Factor Reviews 2011;22:331-8. [DOI: 10.1016/j.cytogfr.2011.11.004] [Cited by in Crossref: 167] [Cited by in F6Publishing: 146] [Article Influence: 16.7] [Reference Citation Analysis]
55 Hertle E, Stehouwer CD, van Greevenbroek MM. The complement system in human cardiometabolic disease. Mol Immunol 2014;61:135-48. [PMID: 25017306 DOI: 10.1016/j.molimm.2014.06.031] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 10.6] [Reference Citation Analysis]
56 Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS. Irisin in patients with nonalcoholic fatty liver disease. Metabolism 2014;63:207-17. [DOI: 10.1016/j.metabol.2013.09.013] [Cited by in Crossref: 129] [Cited by in F6Publishing: 115] [Article Influence: 18.4] [Reference Citation Analysis]
57 Tan BK, Adya R, Randeva HS. Omentin: A Novel Link Between Inflammation, Diabesity, and Cardiovascular Disease. Trends in Cardiovascular Medicine 2010;20:143-8. [DOI: 10.1016/j.tcm.2010.12.002] [Cited by in Crossref: 157] [Cited by in F6Publishing: 118] [Article Influence: 14.3] [Reference Citation Analysis]
58 Bian Z, Ma X. Liver fibrogenesis in non-alcoholic steatohepatitis. Front Physiol 2012;3:248. [PMID: 22934006 DOI: 10.3389/fphys.2012.00248] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
59 Montazerifar F, Bakhshipour AR, Karajibani M, Torki Z, Dashipour AR. Serum omentin-1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease. J Res Med Sci 2017;22:70. [PMID: 28616057 DOI: 10.4103/jrms.JRMS_788_16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
60 Kłusek-Oksiuta M, Bialokoz-Kalinowska I, Tarasów E, Wojtkowska M, Werpachowska I, Lebensztejn DM. Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children. Ital J Pediatr 2014;40:84. [PMID: 25399407 DOI: 10.1186/s13052-014-0084-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
61 Döcke S, Lock JF, Birkenfeld AL, Hoppe S, Lieske S, Rieger A, Raschzok N, Sauer IM, Florian S, Osterhoff MA, Heller R, Herrmann K, Lindenmüller S, Horn P, Bauer M, Weickert MO, Neuhaus P, Stockmann M, Möhlig M, Pfeiffer AFH, von Loeffelholz C. Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. European Journal of Endocrinology 2013;169:547-57. [DOI: 10.1530/eje-13-0112] [Cited by in Crossref: 48] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
62 Akbarzadeh S, Eskandari F, Tangestani H, Bagherinejad ST, Bargahi A, Bazzi P, Daneshi A, Sahrapoor A, O'connor WJ, Rahbar AR. The Effect of Stevia Rebaudiana on Serum Omentin and Visfatin Level in STZ-Induced Diabetic Rats. Journal of Dietary Supplements 2014;12:11-22. [DOI: 10.3109/19390211.2014.901999] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
63 Guzel EC, Celik C, Abali R, Kucukyalcin V, Celik E, Guzel M, Yilmaz M. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome. Gynecological Endocrinology 2014;30:419-22. [DOI: 10.3109/09513590.2014.888412] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 5.1] [Reference Citation Analysis]
64 Neuman MG, French SW, Zakhari S, Malnick S, Seitz HK, Cohen LB, Salaspuro M, Voinea-Griffin A, Barasch A, Kirpich IA, Thomes PG, Schrum LW, Donohue TM Jr, Kharbanda KK, Cruz M, Opris M. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Exp Mol Pathol 2017;102:162-80. [PMID: 28077318 DOI: 10.1016/j.yexmp.2017.01.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
65 Malin SK, Navaneethan SD, Mulya A, Huang H, Kirwan JP. Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults. J Nutr Health Aging 2014;18:608-15. [PMID: 24950152 DOI: 10.1007/s12603-014-0459-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
66 Neves KB, Nguyen Dinh Cat A, Lopes RAM, Rios FJ, Anagnostopoulou A, Lobato NS, de Oliveira AM, Tostes RC, Montezano AC, Touyz RM. Chemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox. Hypertension 2015;66:657-66. [DOI: 10.1161/hypertensionaha.115.05616] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 9.7] [Reference Citation Analysis]